Usefulness of beta-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma

ERDOĞAN K. E., Pacheco M., Gambarotti M., Magagnoli G., Sbaraglia M., Frisoni T., ...Daha Fazla

VIRCHOWS ARCHIV, cilt.479, sa.3, ss.529-535, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 479 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1007/s00428-020-03004-2
  • Dergi Adı: VIRCHOWS ARCHIV
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.529-535
  • Anahtar Kelimeler: Osteoblastoma, Chondroblastoma, Osteosarcoma, Beta-catenin, Immunohistochemistry, Bone
  • Çukurova Üniversitesi Adresli: Evet

Özet

The aim of this study is to assess the usefulness of beta-catenin immunohistochemical expression in the differential diagnosis of osteoid-producing primary tumors of bone. Seventy cases of osteoid-producing tumors of bone (24 conventional osteosarcomas, 18 osteoblastomas, 13 osteoblastoma-like osteosarcomas, 10 chondroblastomas, and 5 chondroblastoma-like osteosarcomas) diagnosed at Istituto Ortopedico Rizzoli were reviewed and evaluated for the intensity, extension, and subcellular distribution of immunohistochemical expression of beta-catenin. A majority of cases (73%, 51 cases) exhibited cytoplasmic and/or membranous positivity in varied degrees of intensity and proportion of positive cells, in the absence of nuclear staining. Fifteen cases (21%) were completely negative, including two osteoblastomas, five chondroblastomas, three conventional osteosarcomas, four osteoblastoma-like osteosarcomas, and one chondroblastoma-like osteosarcoma. A minority of cases (6%) including three osteoblastoma-like osteosarcomas and one osteoblastoma showed focal nuclear beta-catenin positivity with or without concomitant cytoplasmic staining. In the current series, beta-catenin showed not to be useful in the differential diagnosis of osteoid-producing primary bone tumors.